StockData
Eton Pharmaceuticals, Inc. logo

Eton Pharmaceuticals, Inc. (ETON) income statement

ETONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30517% above fair value
$61.99−1.66 (-2.61%)

Close on Nov 18, 2026Market cap $1.77BP/E 158.9Yield –

Eton Pharmaceuticals, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
57.9%
Operating margin
15.4%
Net margin
12.0%
Return on equity, FY2025
-18.2%

Financial strength

Current ratio
1.52
Debt to equity
0.60
Debt to assets
24.1%
Cash to current liabilities
59.5%

Valuation

P/E ratio
158.9
Price to sales
16.78
Price to book
38.04
Dividend yield
–

See a number that looks wrong?